仪器信息网APP
选仪器、听讲座、看资讯

安捷伦调整业务架构并任命两个新业务集团总裁

导读:2014年11月20日,安捷伦宣布,公司已任命两个新的业务集团总裁,并调整业务架构以更好地服务客户。

  2014年11月20日,安捷伦宣布,公司已任命两个新的业务集团总裁,并调整业务架构以更好地服务客户。

  Patrick Kaltenbach被任命为安捷伦高级副总裁,以及旗下生命科学和应用市场业务集团 (LSAG) 总裁。LSAG包含化学分析集团和生命科学业务,这一新的调整将使安捷伦大部分仪器和软件产品业务集中在在一个集团内,更好地服务于具有类似需求的分析实验室。

  Jacob Thaysen被任命为安捷伦高级副总裁,以及旗下诊断和基因业务集团(DGG) 总裁。这个新业务集团包含诊断和基因业务,将更好地服务于临床实验室的需求。

  这两项任命立即生效。

  生命科学和诊断集团 (LDG) 总裁Fred Strohmeier宣布,计划在FY15第二季度退休。目前,他将作为公司的顾问直到退休。

  “我们今天宣布的架构调整,是为了轻松、高效、一个出口服务于我们的客户,”安捷伦总裁、首席运营官和候任首席执行官 Mike McMullen补充道,“我们是根据市场需求调整了业务组织架构,而不是简单根据技术,所做的调整是为了让我们的客户能够以更简单、更直接的方式得到产品、软件和服务。”

  About Patrick Kaltenbach

  As group president for LSAG, Kaltenbach is responsible for leading Agilent's life sciences and applied chemical markets business.

  Kaltenbach was most recently Agilent vice president and general manager of the Life Sciences Products and Solutions organization, where he had responsibility for the strategic direction and development of all Agilent life science products.

  Kaltenbach joined Agilent's predecessor, Hewlett-Packard Co., in 1991 as an R&D engineer in the Capillary Electrophoresis business. He has held various management positions within R&D and senior management roles over the years. Kaltenbach holds a degree in precision engineering from the Karlsruhe University of Applied Science in Germany.

  About Jacob Thaysen

  As group president of DGG, Thaysen is now responsible for the strategic direction and day-to-day management of Agilent's diagnostics and genomics business.

  Thaysen was most recently vice president and general manager of Agilent's Diagnostics and Genomics business within LDG. He was responsible for its overall operation, including strategic direction, project management, sales, marketing and R&D.

  Thaysen joined Agilent in 2012 as part of the Dako acquisition. He was corporate vice president of R&D at Dako, and prior to that a management consultant at Copenhagen Consulting Co. (now Quartz+Co.). Previously, he was a founding partner and chief technology officer of Cantion, a research and defense application development company.

  He holds a Ph.D. in physics from the Technical University of Denmark.

来源于:仪器信息网译

打开APP,掌握第一手行业动态
打赏
点赞

相关会议

更多

热门评论

写评论…
0

  2014年11月20日,安捷伦宣布,公司已任命两个新的业务集团总裁,并调整业务架构以更好地服务客户。

  Patrick Kaltenbach被任命为安捷伦高级副总裁,以及旗下生命科学和应用市场业务集团 (LSAG) 总裁。LSAG包含化学分析集团和生命科学业务,这一新的调整将使安捷伦大部分仪器和软件产品业务集中在在一个集团内,更好地服务于具有类似需求的分析实验室。

  Jacob Thaysen被任命为安捷伦高级副总裁,以及旗下诊断和基因业务集团(DGG) 总裁。这个新业务集团包含诊断和基因业务,将更好地服务于临床实验室的需求。

  这两项任命立即生效。

  生命科学和诊断集团 (LDG) 总裁Fred Strohmeier宣布,计划在FY15第二季度退休。目前,他将作为公司的顾问直到退休。

  “我们今天宣布的架构调整,是为了轻松、高效、一个出口服务于我们的客户,”安捷伦总裁、首席运营官和候任首席执行官 Mike McMullen补充道,“我们是根据市场需求调整了业务组织架构,而不是简单根据技术,所做的调整是为了让我们的客户能够以更简单、更直接的方式得到产品、软件和服务。”

  About Patrick Kaltenbach

  As group president for LSAG, Kaltenbach is responsible for leading Agilent's life sciences and applied chemical markets business.

  Kaltenbach was most recently Agilent vice president and general manager of the Life Sciences Products and Solutions organization, where he had responsibility for the strategic direction and development of all Agilent life science products.

  Kaltenbach joined Agilent's predecessor, Hewlett-Packard Co., in 1991 as an R&D engineer in the Capillary Electrophoresis business. He has held various management positions within R&D and senior management roles over the years. Kaltenbach holds a degree in precision engineering from the Karlsruhe University of Applied Science in Germany.

  About Jacob Thaysen

  As group president of DGG, Thaysen is now responsible for the strategic direction and day-to-day management of Agilent's diagnostics and genomics business.

  Thaysen was most recently vice president and general manager of Agilent's Diagnostics and Genomics business within LDG. He was responsible for its overall operation, including strategic direction, project management, sales, marketing and R&D.

  Thaysen joined Agilent in 2012 as part of the Dako acquisition. He was corporate vice president of R&D at Dako, and prior to that a management consultant at Copenhagen Consulting Co. (now Quartz+Co.). Previously, he was a founding partner and chief technology officer of Cantion, a research and defense application development company.

  He holds a Ph.D. in physics from the Technical University of Denmark.